|
[1]
|
Le Berre, C., Honap, S. and Peyrin-Biroulet, L. (2023) Ulcerative Colitis. The Lancet, 402, 571-584. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Ng, S.C., Shi, H.Y., Hamidi, N., Underwood, F.E., Tang, W., Benchimol, E.I., et al. (2017) Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21st Century: A Systematic Review of Population-Based Studies. The Lancet, 390, 2769-2778. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Kiesler, P., Fuss, I.J. and Strober, W. (2015) Experimental Models of Inflammatory Bowel Diseases. Cellular and Molecular Gastroenterology and Hepatology, 1, 154-170. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Yang, L., Gao, H. and Liu, D. (2025) Advance on Establishment of Pathological Model of Ulcerative Colitis. Frontiers in Veterinary Science, 12, Article 1618260. [Google Scholar] [CrossRef]
|
|
[5]
|
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y. and Nakaya, R. (1990) A Novel Method in the Induction of Reliable Experimental Acute and Chronic Ulcerative Colitis in Mice. Gastroenterology, 98, 694-702. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chassaing, B., Aitken, J.D., Malleshappa, M. and Vijay‐Kumar, M. (2014) Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice. Current Protocols in Immunology, 104, 15.25.1-15.25.14. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Wirtz, S., Popp, V., Kindermann, M., Gerlach, K., Weigmann, B., Fichtner-Feigl, S., et al. (2017) Chemically Induced Mouse Models of Acute and Chronic Intestinal Inflammation. Nature Protocols, 12, 1295-1309. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wirtz, S., Neufert, C., Weigmann, B. and Neurath, M.F. (2007) Chemically Induced Mouse Models of Intestinal Inflammation. Nature Protocols, 2, 541-546. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Silva, I., Solas, J., Pinto, R. and Mateus, V. (2022) Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease. International Journal of Molecular Sciences, 23, Article 4739. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Katsandegwaza, B., Horsnell, W. and Smith, K. (2022) Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease. International Journal of Molecular Sciences, 23, Article 9344. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Morris, G.P., Beck, P.L., Herridge, M.S., Depew, W.T., Szewczuk, M.R. and Wallace, J.L. (1989) Hapten-Induced Model of Chronic Inflammation and Ulceration in the Rat Colon. Gastroenterology, 96, 795-803. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Shi, Y., Liu, Z., Cui, X., Zhao, Q. and Liu, T. (2020) Intestinal Vitamin D Receptor Knockout Protects from Oxazolone-Induced Colitis. Cell Death & Disease, 11, Article No. 461. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Zhao, Z., Yuan, X., Cui, Y., Liu, J., Shen, J., Jin, B., et al. (2022) Melatonin Mitigates Oxazolone-Induced Colitis in Microbiota-Dependent Manner. Frontiers in Immunology, 12, Article ID: 783806. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zhang, L., Cao, N., Wang, Y., Wang, Y., Wu, C., Cheng, X., et al. (2019) Improvement of Oxazolone-Induced Ulcerative Colitis in Rats Using Andrographolide. Molecules, 25, Article 76. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Boirivant, M., Fuss, I.J., Chu, A. and Strober, W. (1998) Oxazolone Colitis: A Murine Model of T Helper Cell Type 2 Colitis Treatable with Antibodies to Interleukin 4. The Journal of Experimental Medicine, 188, 1929-1939. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Powrie, F., Leach, M.W., Mauze, S., Caddie, L.B. and Coffman, R.L. (1993) Phenotypically Distinct Subsets of CD4+ T Cells Induce or Protect from Chronic Intestinal Inflammation in C. B-17 Scid Mice. International Immunology, 5, 1461-1471. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K. and Müller, W. (1993) Interleukin-10-Deficient Mice Develop Chronic Enterocolitis. Cell, 75, 263-274. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Mombaerts, P., Mizoguchi, E., Grusby, M.J., Glimcher, L.H., Bhan, A.K. and Tonegawa, S. (1993) Spontaneous Development of Inflammatory Bowel Disease in T Cell Receptor Mutant Mice. Cell, 75, 275-282. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sundberg, J.P., Elson, C.O., Bedigian, H. and Birkenmeier, E.H. (1994) Spontaneous, Heritable Colitis in a New Substrain of C3H/HeJ Mice. Gastroenterology, 107, 1726-1735. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Mizoguchi, A., Takeuchi, T., Himuro, H., et al. (2022) Genomic and Translational Aspects of Inflammatory Bowel Disease Mouse Models: How Far Have We Come? Inflammatory Bowel Diseases, 28, 124-136.
|
|
[21]
|
de Souza, H.S.P., Fiocchi, C. and Iliopoulos, D. (2017) The IBD Interactome: An Integrated View of Aetiology, Pathogenesis and Therapy. Nature Reviews Gastroenterology & Hepatology, 14, 739-749. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., et al. (2006) IL-23 Is Essential for T Cell-Mediated Colitis and Promotes Inflammation via IL-17 and IL-6. Journal of Clinical Investigation, 116, 1310-1316. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Ungaro, R., Mehandru, S., Allen, P.B., Peyrin-Biroulet, L. and Colombel, J. (2017) Ulcerative Colitis. The Lancet, 389, 1756-1770. [Google Scholar] [CrossRef] [PubMed]
|